Welcome to the Haematological
Malignancy Research Network (HMRN)
This site is for anyone interested in haematological cancers (leukaemias, lymphomas and myelomas) and related blood disorders. It contains statistics and other
information for clinicians and researchers.
Much of the material presented is sourced from the population-based patient cohort that lies at the centre of the UK’s Haematological Malignancy Research Network (HMRN).
Within this cohort, the comprehensive follow-up and routine linkage of diagnostic and prognostic data to information on outcome and treatment provides a unique
opportunity to gain insight into aspects of haematological cancer that cannot be studied elsewhere.